We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARI
2001
Apollo Commercial Real Estate
ARI
$885M
| $4.01M | ﹤0.01% |
482,602
-8,992
| -2% | -$103K |
|
2002
Collegium Pharmaceutical
COLL
$956M
| $3.99M | ﹤0.01% |
249,268
-2,781
| -1% | -$49K |
|
2003
Protolabs
PRLB
$2.13B
| $3.99M | ﹤0.01% |
109,575
-3,624
| -3% | -$157K |
|
2004
Syndax Pharmaceuticals
SNDX
$1.82B
| $3.99M | ﹤0.01% |
165,877
+35
| +0% | +$785 |
|
2005
Koppers
KOP
$969M
| $3.98M | ﹤0.01% |
191,733
-2,140
| -1% | -$49.3K |
|
2006
IDEAYA Biosciences
IDYA
$3.56B
| $3.98M | ﹤0.01% |
266,816
+21,010
| +9% | +$273K |
|
|
OSG
2007
Octave Specialty Group
OSG
$222M
| $3.98M | ﹤0.01% |
311,939
+142,403
| +84% | +$1.9M |
|
|
TGH
2008
DELISTED
Textainer Group Holdings limited
TGH
| $3.97M | ﹤0.01% |
147,673
-7,093
| -5% | -$215K |
|
2009
Sphere Entertainment
SPHR
$5.73B
| $3.96M | ﹤0.01% |
89,884
-1,376
| -2% | -$77.2K |
|
2010
Modine Manufacturing
MOD
$10.4B
| $3.96M | ﹤0.01% |
306,140
-81,454
| -21% | -$1.14M |
|
2011
Peapack-Gladstone Financial
PGC
$812M
| $3.96M | ﹤0.01% |
117,540
+9,181
| +8% | +$302K |
|
2012
Vital Farms
VITL
$525M
| $3.94M | ﹤0.01% |
329,310
-217,657
| -40% | -$2.6M |
|
2013
Scholastic
SCHL
$792M
| $3.94M | ﹤0.01% |
128,084
-51,278
| -29% | -$2.14M |
|
2014
Alamo Group
ALG
$2.05B
| $3.93M | ﹤0.01% |
32,166
-595
| -2% | -$75.7K |
|
2015
Schrodinger
SDGR
$1.36B
| $3.93M | ﹤0.01% |
157,247
-1,292
| -0.8% | -$38K |
|
2016
Safety Insurance
SAFT
$1.52B
| $3.92M | ﹤0.01% |
48,100
-1,349
| -3% | -$122K |
|
2017
ESAB
ESAB
$5.71B
| $3.91M | ﹤0.01% |
117,280
-3,186
| -3% | -$131K |
|
2018
Opendoor
OPEN
$3.38B
| $3.9M | ﹤0.01% |
1,297,480
-102,869
| -7% | -$472K |
|
2019
Alpha and Omega Semiconductor
AOSL
$1.08B
| $3.9M | ﹤0.01% |
126,874
-52,528
| -29% | -$1.94M |
|
2020
Tower Semiconductor
TSEM
$28.5B
| $3.89M | ﹤0.01% |
88,576
-414
| -0.5% | -$19.1K |
|
2021
Varex Imaging
VREX
$523M
| $3.89M | ﹤0.01% |
183,994
-3,300
| -2% | -$72.2K |
|
|
TWO
2022
Two Harbors Investment
TWO
$1.27B
| $3.88M | ﹤0.01% |
292,148
-4,744
| -2% | -$92.1K |
|
|
EB
2023
DELISTED
Eventbrite
EB
| $3.88M | ﹤0.01% |
637,937
+201,787
| +46% | +$1.7M |
|
2024
S&T Bancorp
STBA
$1.79B
| $3.85M | ﹤0.01% |
131,491
-3,834
| -3% | -$115K |
|
2025
Compass Diversified
CODI
$828M
| $3.81M | ﹤0.01% |
210,970
-76,550
| -27% | -$1.68M |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.